Logo image
Sign in
Back
LBP01 - Multifactorial effects of AXA1125 and AXA1957 observed on markers of metabolism, inflammation and fibrosis: a 16-week randomized placebo-controlled study in subjects with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes (T2D)
Journal article   Open access  Peer reviewed

LBP01 - Multifactorial effects of AXA1125 and AXA1957 observed on markers of metabolism, inflammation and fibrosis: a 16-week randomized placebo-controlled study in subjects with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes (T2D)

Stephen A. Harrison, Seth J. Baum, Nadege T. Gunn, Ziad H. Younes, Anita Kohli, Rashmee Patil, Margaret J. Koziel, Harinder Chera, Jeff Zhao and Manu V. Chakravarthy
Journal of hepatology, Vol.73, pp.S123-S123
08/2020
DOI: https://doi.org/10.1016/S0168-8278(20)30763-7
url
https://doi.org/10.1016/S0168-8278(20)30763-7View
Published (Version of record) Open

Metrics

4 Record Views

Details